The antidepressant clomipramine may also alleviate symptoms of multiple sclerosis (MS), specifically in its progressive form, i.e. when it occurs without relapses or remissions. As yet, drugs for this type of MS have been ...
Dec 20, 2017
0
61
Researchers examined the insurance claims and medical records of 681 patients with multiple sclerosis (MS) and found those who adhered to medication schedules had significantly better physical outcomes than patients who did ...
Nov 27, 2017
0
0
New research supports the idea that multiple sclerosis (MS), which has widely varying symptoms and progression in different patients, is nonetheless a single disease with common underlying mechanisms. The findings are published ...
Oct 26, 2017
0
12
(HealthDay)—Patients with multiple sclerosis (MS) have peripheral nerve involvement that can be visualized and quantified by high-resolution magnetic resonance neurography (MRN), according to a study published online Oct. ...
Oct 26, 2017
0
0
An article published in Experimental Biology and Medicine (Volume 242, Issue 15, September, 2017) identifies opioid growth factor (OGF) as a novel biomarker for the onset and progression of multiple sclerosis (MS). The study, ...
Sep 27, 2017
0
21
Scientists have uncovered two closely related cytokines—molecules involved in cell communication and movement—that may explain why some people develop progressive multiple sclerosis (MS), the most severe form of the disease. ...
Sep 18, 2017
0
49
Researchers at UC San Francisco have identified specific gut microbes associated with multiple sclerosis (MS) in human patients, showing that these microbes take part in regulating immune responses in mouse models of the ...
Sep 11, 2017
0
2521
For most of us, the flu is just the flu. We suffer through it for several days, and eventually bounce back. But for patients with multiple sclerosis (MS) and other neurological diseases, the flu can trigger a cascade of immune ...
Aug 8, 2017
0
60
Neurologist Dr. Matthew Tremblay, who specializes in the care of patients with multiple sclerosis at UConn Health, discusses the first drug just approved by the FDA for patients with difficult to treat primary progressive ...
Mar 31, 2017
0
5
In the relentless battle against multiple sclerosis (MS), U of A researchers recently discovered an entirely new cellular mechanism—an underlying defect in brain cells—that may to be blame for the disease, and a potential ...
Mar 23, 2017
0
69
